Weight Loss Research Study
Obese patients often also have Nonalcoholic Fatty Liver Disease (NAFLD). NAFLD prevalence in the general population has been estimated at 20%. Treatment of NAFLD/NASH generally includes weight loss and glycemic control if the patient is diabetic or prediabetic.
That is why Tandem Clinical Research is looking for volunteers for a research study of an investigational NAFLD medication designed to help reduce weight and liver fat. To qualify, you must:
- Be 22 to 65 years of age
- Be obese or overweight with or without diabetes
Qualified participants will receive study-related medication and care. Compensation for time and travel may be available. To learn more or schedule an appointment, complete the form below!